Somaxon Announces FDA Approval Of Silenor(R) (doxepin) For The Treatment Of Insomnia

March 19th, 2010 Posted in Sleeping Disorders

Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia characterized by difficulty with sleep maintenance…

%Sleep Problems%

Recommended sleep disorder sites

Sleep Problems
Sleep Problems
Sleep Disorders
Sleep Net
Sleep Disorders

Posts Related to Somaxon Announces FDA Approval Of Silenor(R) (doxepin) For The Treatment Of Insomnia

Cephalon Receives Complete Response Letter For NUVIGIL For The Treatment Of Excessive Sleepiness Associated With Jet Lag Disorder
Cephalon, Inc. (Nasdaq: CEPH) announced the company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for its supplemental new ...
Silenor Insomnia Drug Still Unapproved
For the second time in a row the Silenor drug for Insomnia has been declined. Apparently the drug did not meet the approval standards for ...
Insomnia Treated with Homeopathy
Before taking over the counter medications for your insomnia , or even worse, prescription drugs, go visit an homeopath for a holistic treatment of your ...
Novel Patent Targets The Most Common Sleep Complaint: Chronic Insomnia
Consolidated Research of Richmond, Inc. (CRI) announces the awarding of United States Patent 7,654,948 - which is a novel, drug-free system for treating people suffering ...
What is Restless Leg Syndrome?
Restless legs syndrome (RLS) is a neurological disorder characterized by unpleasant sensations in the legs and an uncontrollable urge to move them for relief. Individuals ...